Follicular lymphoma showing avid uptake on 68Ga PSMA-HBED-CC PET/CT

Clinical Nuclear Medicine

Volumn 41, Issue 6, 2016, Pages 500-501

  Kanthan, Gowri L ^a   Coyle, Luke ^b   Kneebone, Andrew ^a   Schembri, Geoffrey Paul ^a   Hsiao, Edward ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b Department of Haematology ^*  (Australia)

Author keywords

68Ga PSMA PET CT; Follicular lymphoma; Prostate carcinoma

Indexed keywords

PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN GA 68; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; EDETIC ACID; GALLIUM; GLU-NH-CO-NH-LYS-(AHX)-((68)GA(HBED-CC)); OLIGOPEPTIDE;

AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG UPTAKE; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; MALE; PROSTATE CARCINOMA; ANALOGS AND DERIVATIVES; CARCINOMA; DIAGNOSTIC IMAGING; LARGE CORE NEEDLE BIOPSY; LYMPH NODE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PROSTATE TUMOR; SECOND CANCER; THIGH;

AGED; BIOPSY, LARGE-CORE NEEDLE; CARCINOMA; EDETIC ACID; GALLIUM RADIOISOTOPES; HUMANS; LYMPH NODES; LYMPHOMA, FOLLICULAR; MALE; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; OLIGOPEPTIDES; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PROSTATIC NEOPLASMS; THIGH;

EID: 84959127039     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000001169     Document Type: Article

References (8)

1. 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2015; 42:197-209.
2. Chang SS. Overview of prostate-specific membrane antigen. Rev Urol. 2004; 6(Suppl 10):S13-S18.
3. 68Ga-PSMA ligand PET/CTin 248 patients with biochemical recurrence after radical prostatectomy. J Nucl Med. 1995;56:668-674.
4. Afshar-Oromieh A, Zechmann CM, Malcher A, et al. Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2014;41:11-20.
5. Chang SS, Reuter VE, Heston WD, et al. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res. 1999;59:3192-3198.
6. Demirci E, Ocak M, Kabasakal L, et al. (68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma. Eur J Nucl Med Mol Imaging. 2014;41:1461-1462.
7. Wang W, Tavora F, Sharma R, et al. PSMA expression in Schwannoma: a potential clinical mimicker of metastatic prostate carcinoma. Urol Oncol. 2009; 27:525-528.
8. 68Ga PSMA-HBED-CC PET/CT. Clin Nucl Med. 2016;41:331-332.